Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Lifestyle changes, dietary restrictions, and nutraceuticals in migraine prevention
Techniques in Regional Anesthesia and Pain Management, 06/25/09
Taylor FR - This article discusses this practitioner's empiric recommendation for lifestyle changes and graded evidence for dietary changes and nutraceuticals in migraineurs. Alcohol, aspartame, nitrates, and monosodium glutamate are Grade B-rated dietary substances needing restriction, with MSG lacking data specific for migraine. No consensus yet exists on the hierarchy of efficacy for the nutraceuticals. Given the number of patients studied and data consistency or lack thereof regarding efficacy, Petadolex appears to have best proof followed by magnesium > feverfew (no commercially available MIG-99 forms) > riboflavin > coenzyme Q10 > thiotic acid.
Today in Neurology/Neurosurgery...keeping you current
Receive free subspecialty "5-minute updates" via email
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09
Safety and Efficacy of IV-TPA for Ischaemic Stroke in Clinical Practice - A Bayesian Analysis
Cerebrovascular Diseases, 10/30/09
Today in Preventive Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic
Annals of Internal Medicine, 10/13/09
One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09
Article Search
Sponsor


See Latest Articles


